Healthcare Equipment and Supplies
Company Overview of K2M, Inc.
K2M, Inc. engages in the research, development, and commercialization of solutions for the treatment of spinal pathologies and procedures. It offers deformity correction systems, spinal stabilization systems, lateral access systems, minimally invasive systems, and constrained and translational cervical plates. The company also provides motion preservation, annular repair, and nucleus replacement technologies for the treatment of deformity, degenerative, trauma, and tumor spinal patients. In addition, it offers osteobiologic systems that enhance bone regeneration after spine surgery and allograft systems; foam strips and granules bone graft systems; small corpectomy cage system to address col...
751 Miller Drive SE
Leesburg, VA 20175
Founded in 2004
Key Executives for K2M, Inc.
Co-Founder, Chief Executive Officer, President and Director
Co-Founder, Chief Medical Officer, Chief Scientific Officer, Head of Board of Scientific Advisors and Director
Senior Vice President of Operations
Senior Vice President, Compliance Officer, General Counsel and Secretary
Compensation as of Fiscal Year 2014.
K2M, Inc. Key Developments
K2M Announces Amendments to Its Credit Agreement
Jan 9 15
On January 7, 2015, subsidiaries of K2M Group Holdings, Inc. entered into an amendment to the company's senior secured credit facilities credit agreement, dated as of October 29, 2012, by and among K2M Holdings, Inc. as the guarantor, K2M, Inc. and K2M UK Limited as the borrower, and Silicon Valley Bank and Comerica Bank as lenders. The Fifth Amendment, among other things, amended and restated the definition of "Available Revolving Commitment" under the Credit Agreement in order to exclude the Company's issued and outstanding Letters of Credit under the Credit Agreement's $10 million Letter of Credit sub-facility from the calculation of the Company's borrowing capacity under the Credit Agreement. The Letters of Credit will be considered when determining the Total Revolving Commitments, as defined under the Credit Agreement, which, remain unchanged at $40 million.
K2M, Inc. Receives 510(K) Clearance from the FDA for its CAPRI Corpectomy Cage System
Nov 14 14
K2M, Inc. received 510(k) clearance from the FDA for its CAPRI Corpectomy Cage System, an expandable vertebral body replacement device that provides structural stability following a corpectomy or vertebrectomy. The CAPRI Corpectomy Cage System is intended for use in the thoracolumbar spine (T1 to L5) to replace collapsed, damaged or unstable vertebral bodies due to tumor or trauma. The CAPRI Corpectomy Cage System is designed to provide anterior spinal column support even in the absence of fusion for a prolonged period.
K2M Group Holdings, Inc., K2M, Inc. and K2M UK Limited Limited Announces Fourth Amendment to Senior Secured Credit Facilities Credit Agreement
Oct 24 14
On October 21, 2014, subsidiaries of K2M Group Holdings, Inc. entered into an amendment to the Company's senior secured credit facilities credit agreement, dated as of October 29, 2012, by and among K2M Holdings, Inc. as the guarantor, K2M, Inc. and K2M UK Limited as the borrower, and Silicon Valley Bank and Comerica Bank as lenders. The Fourth Amendment, among other things, extends the maturity date of the revolving credit facility to October 2015, increases the total revolving commitments from $30 million to $40 million and increases the letter of credit sub-facility from $1 million to $10 million. In addition, the Fourth Amendment removes the sub-facility provided by the Export-Import Bank of the United States, which had been a party to the prior loan agreements. ABR loans under the revolving credit facility bear interest at a rate per annum equal to ABR, plus 0.75%. LIBOR loans under the revolving credit facility bear interest at a rate per annum equal to the greater of (i) LIBOR, plus 2.50% or (ii) 3.75%. The total obligations under the amended credit facility cannot exceed (i) the lesser of the total revolving commitment of $40 million or (ii) the borrowing base, which is calculated as (x) 85% of accounts receivable so long as certain of those accounts receivable do not exceed, in the aggregate, 50% of the borrowing base plus (y) 35% of the value of the eligible inventory provided that the contribution of the value of the eligible inventory not exceed the less of 40% of the borrowing base or $10 million. Borrowings under the revolving credit facility remain secured by a first priority lien on all of the Borrower's personal property assets, including intellectual property.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|